Providing treatment for patients in brisbane australia.
Stem cell knee cartilage repair australia.
This trial aims to compare the effect of the patient s own fat stem cells in the treatment of osteoarthritis of the knee.
Stem cell therapy could also potentially treat osteoarthritis oa of the knee.
The biggest stem cell trial of its type in the world has proved beyond doubt that pure stem cells provide a more effective treatment for osteoarthritis than traditional therapies such as pain relief drugs anti inflammatories prescribed exercise and knee surgery.
In oa the cartilage covering the ends of the bones starts to deteriorate and wear away.
The stem cells derived from these tissues primarily aid cartilage repair.
Brisbane regeneration is the leading provider of stem cell therapy treatment for osteoarthritis.
This phase ii study seeks to determine the effectiveness of using the patient s own adipose derived mesenchymal stem cell to repair cartilage defects.
Although stem cells can be differentiated into chondrocytes in vitro or aid cartilage regeneration in vivo their potential for osteoarthritis management remains limited as cartilage regenerated by stem cells fails to fully recapitulate the structural and biomechanical.
For example a young athlete with a normal knee sustains a ligament injury and associated cartilage damage.
The trial is being conducted by the lakeside medical centre in albert park and the australian catholic university in melbourne.
The food and drug administration approved the use of this technique known as recycled cartilage auto allo implantation reclaim in a trial utilizing the stem cell bank in the mayo clinic center for regenerative medicine.
We don t have a lot of controlled trials yet says keith bjork md an orthopedist in amarillo tx who has given stem cell treatments to about 500 patients with knee arthritis in the past 5 years.
The hope is that injecting stem cells may help stimulate the body to repair that damage before the cartilage is irreparably harmed.
Mayo clinic offers a unique regenerative medicine approach for repairing knee cartilage which can be completed in a single surgery.
The trial that has not started yet according to the registration information but proposes to recruit 60 patients.
The structure of their knee is normal but the cartilage was damaged.
Half will have arthroscopic microfracture and mesenchymal stem cells administered weekly for up to 13 weeks post surgery while the other half will have.